San Jose, CA, United States of America

Barnett B Rosenblum

USPTO Granted Patents = 65 

 

Average Co-Inventor Count = 3.6

ph-index = 26

Forward Citations = 2,210(Granted Patents)


Inventors with similar research interests:


Location History:

  • Foster City, CA (US) (1999)
  • San Jose, CA (US) (1998 - 2022)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
65 patents (USPTO):

Title: Barnett B Rosenblum: Pioneering Innovator in Nucleotide Sequencing Technologies

Introduction:

Barnett B Rosenblum, a visionary inventor based in San Jose, CA, has made significant contributions to the field of nucleotide sequencing technologies. With a remarkable portfolio of 64 patents, Rosenblum is renowned for his relentless drive to push the boundaries of technology and innovation.

Latest Patents:

1. Nucleotide Transient Binding for Sequencing Methods: Rosenblum's innovative method involves the use of polymerase-dependent, nucleotide transient-binding techniques for sequencing nucleic acid molecules and conducting single nucleotide polymorphism (SNP) analyses. The approach capitalizes on the distinct binding times of complementary and non-complementary nucleotides to the polymerase, enabling accurate sequencing.

2. Thiolated Nucleotide Analogues for Nucleic Acid Synthesis: Rosenblum's invention focuses on extending nucleic acids by incorporating nucleotide residues with thiophosphate moieties. These nucleotides are resistant to phosphatase hydrolysis, facilitating efficient nucleotide incorporation using a polymerase enzyme under various reaction conditions.

Career Highlights:

Rosenblum has worked with prominent companies such as Life Technologies Corporation and Applera Corporation, where he has honed his expertise in nucleic acid synthesis and sequencing technologies. His innovative mindset and technical prowess have been instrumental in driving advancements in the field.

Collaborations:

Throughout his career, Rosenblum has collaborated closely with esteemed professionals in the industry, including Linda G Lee and Steven Menchen. These fruitful partnerships have led to significant breakthroughs in nucleotide sequencing methodologies and have cemented Rosenblum's reputation as a trailblazer in the field.

Conclusion:

Barnett B Rosenblum's passion for innovation and his unwavering commitment to advancing nucleotide sequencing technologies have established him as a visionary inventor in the ever-evolving landscape of inventions and patents. His groundbreaking work continues to shape the future of genetic analysis and molecular diagnostics, leaving a lasting impact on the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…